Tag: LEXX

Lexaria Bioscience Corp. is gearing up to kick off an innovative 8-week animal study, codenamed WEIGHT-A24-1, on March 5, 2024. ...

Lexaria Bioscience has recently obtained FDA approval for its upcoming U.S. Phase 1b Hypertension Clinical Trial, known as HYPER-H23-1, set ...

On February 15, 2024, Lexaria Bioscience Corp. (NASDAQ: LEXX) revealed exciting news about its latest financial move. The company has ...